Get Published | Subscribe | About | Write for Our Blog    

News RSS Bioethics News.


The coronavirus outbreak exposes the U.S.’s pharma supply chain vulnerability

External Link - Source: STAT

In October 2019, Dr. Janet Woodcock, the director of the FDA’s Center for Drug Evaluation and Research, testified before Congress that the United States “has become a world leader in drug discovery and development, but is no longer in the forefront of drug manufacturing.” The use of foreign-sourced materials “creates vulnerabilities in the U.S. supply chain,” Woodcock concluded.

This entry was posted in Pharmaceuticals. Bookmark the permalink.